Exploring the Trajectory of Catatonia in Neurodiverse and Neurotypical Pediatric Hospitalizations: A Multicenter Longitudinal Analysis
Preprint
Abstract
Objective: Catatonia is a neuropsychiatric disorder that occurs in pediatric patients with a range of associated medical, psychiatric, and neurodevelopmental disorders (NDDs). This study describes hospital care of pediatric catatonia patients and compares treatments for neurotypical patients and those with NDDs. Methods: Retrospective cohort study from 1/1/2018 to 6/1/2023 of two academic medical centers of patients aged 18 and younger with catatonia. Patients were retrospectively assessed using the clinical global impressions-improvement (CGI-I) by two independent reviewers. Results: One hundred sixty-five patients were hospitalized for catatonia, of whom 50.3% had an NDD. Median age was 15. One hundred sixty-four patients were treated with a benzodiazepine, with a median maximum 24-hour dose of 6 mg lorazepam-equivalents, which did not differ for patients with and without NDDs. Electroconvulsive therapy (ECT) was utilized in 14.5% of patients. Median length of medical hospitalization was 5 days and hospitalizations were longer in neurotypical patients than in patients with NDDs. In an ordinal regression model, the probability of observing at least “much improvement” (CGI < 3) was 88.3% (95% CI: 82.4% to 92.3%), with NDD diagnosis associated with a lower odds of clinical response. Conclusions: The probability of patients achieving a CGI-I score indicating at least “much improvement” was 88.3%. Administered benzodiazepine dose and ECT treatment were similar for all patients, but neurotypical patients had longer hospitalizations than those with NDDs and had a higher odds of a more favorable clinical response. Research under controlled conditions is needed to optimize and endure equitable catatonia treatment in youth.Keywords
This publication has 35 references indexed in Scilit:
- Symptoms of Catatonia Observed in Down Syndrome Regressive Disorder: A Retrospective AnalysisJournal of Autism and Developmental Disorders, 2024
- Regulatory and Service System Challenges in Accessing Electroconvulsive Therapy for Catatonia in the Presence of Autism Spectrum DisorderJournal of the American Academy of Child & Adolescent Psychiatry, 2023
- Factor analysis and validation of the Bush Francis catatonia rating scale-Spain versionThe European Journal of Psychiatry, 2023
- Manifestation of Catatonia in an Adolescent With 22q11.2 SyndromeJournal of the American Academy of Child & Adolescent Psychiatry, 2023
- The use of electroconvulsive therapy for children and adolescents in general hospitals: A 2019 kids' inpatient database analysisGeneral Hospital Psychiatry, 2023
- Use of ECT in Autism Spectrum Disorder and/or Intellectual Disability: A Single Site Retrospective AnalysisJournal of Autism and Developmental Disorders, 2022
- Morbidity Due to Disparity in Pediatric Electroconvulsive TherapyJournal of the American Academy of Child & Adolescent Psychiatry, 2022
- Catatonia in Children and Adolescents: A High Rate of Genetic ConditionsJournal of the American Academy of Child & Adolescent Psychiatry, 2018
- Measuring catatonia: A systematic review of rating scalesJournal of Affective Disorders, 2011
- Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled cross-over studyPsychopharmacology, 1999